The North America Cell Separation Market would witness market growth of 9.5% CAGR during the forecast period (2023-2030).
The rise in chronic diseases is predicted to accelerate the adoption of cell separation technologies such as the development of regenerative medicines or tissue engineering. The market is expected to expand throughout the forecasted period due to technological advancements in cell separation technologies and increased government initiatives to support the cell separation procedure.
Over 1.9 million new cases of cancer are anticipated to be diagnosed in the United States alone in 2023, according to the American Cancer Society. Around 1.5 million new cases of hepatitis C are reported each year, and the WHO estimates that 58 million individuals regionally have chronic hepatitis C infection. Instruments and related products are indispensable in disease diagnosis and scientific research, as they can produce accurate and reliable results.
Government initiatives and legislation about biomedical research activities are escalating quickly due to increased public awareness of the aging population and the rising frequency of chronic diseases. The market expanded quickly as a result of this. Market’s growth is predicted to be accelerated by investments in the biotechnology industry and improvements to the healthcare infrastructure.
Cancer has a significant impact on the United States. The number of new cancer cases expected to be diagnosed in the US in 2020 was 1,806,590, while the number of cancer-related deaths is predicted to be 606,520. There were reportedly 16.9 million cancer survivors in the United States as of January 2019. Up to 2030, there are expected to be 22.2 million cancer survivors. There were 2,122 HIV diagnoses reported in Canada overall 2019 (5.6 per 100,000 people). At 16.9 per 100,000 population, Saskatchewan had the greatest provincial diagnosis rate. At 12.7 per 100,000 people, the age group of 30 to 39 had the highest prevalence of HIV diagnosis. As a result of the rising HIV/AIDS and cancer patients across the regional nations, the market is estimated to grow at a steady rate.
The US market dominated the North America Cell Separation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,780.7 million by 2030. The Canada market is experiencing a CAGR of 12% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 11% during (2023 - 2030).
Based on Product Type, the market is segmented into Consumables (Reagents, Kits, Media, & Sera, Disposables, and Beads), and Instruments (Centrifuges, Flow Cytometers, Filtration Systems, and Magnetic-activated Cell Separator Systems). Based on End-Use, the market is segmented into Biotechnology & Biopharmaceutical Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, and Cell Banks. Based on Cells Type, the market is segmented into Animal Cell, and Human Cell. Based on Technique, the market is segmented into Centrifugation, Surface Marker, and Filtration. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, and Therapeutics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Cell Separation Market is Projected to reach USD 17.5 Billion by 2030, at a CAGR of 10.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Corning Incorporated, Terumo Corporation, STEMCELL Technologies, Inc. and Akadeum Life Sciences, Inc.
By Product Type
By End-Use
By Cells Type
By Technique
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
